Naltrexone implant not checked
FollowEvery change as it happens, and a Monday email
Trials
1 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Subcutaneous bioresorbable implant containing 9.6 grams of naltrexone, inserted into the thigh on Day 1 and designed to release drug steadily over 12 months.”In the company’s words, NCT07064564 on ClinicalTrials.gov
- Tested for
- Opioid Use Disorder
- Main trialPhase 1
- “This Phase 1b clinical study evaluates iSTEP-N, an investigational extended-release subcutaneous implant containing 9.6 g of naltrexone designed to provide continuous drug release over many months. The primary objective is to evaluate naltrexone plasma concentrations and pharmacokinetic (PK) parameters over 12 months following a single iSTEP-N implant placement compared with monthly intramuscular injections of Vivitrol® (380 mg) in healthy adult volunteers. Participants are randomized in a 4:3 ratio to receive either a single 9.6 g iSTEP-N implant (n=12) or monthly Vivitrol injections…”In the company’s words, NCT07064564 on ClinicalTrials.gov
Other drugs for Opioid Use Disorder
- PEX010-AssistedFilament Health Corp. · Phase 2
- CebranopadolAdneuris Therapeutics, Inc. · Tris Pharma, Inc. · Phase 2
- BrenipatideEli Lilly · Phase 2
- Ibogaine HydrochlorideClive Michelsen · Phase 1/2
- Naltrexone implantGo Medical Industries Pty Ltd · Phase 2
- 1 Nalmefene implantReacX Pharmaceuticals, Inc. · Phase 1
Coming up1
- 1 Oct 2029Phase 1 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Active, not recruiting | 1 Oct 2029 | iSTEP-N 101b: Pharmacokinetics and Safety Study of iSTEP-N Implant vs Monthly Vivitrol in Healthy Volunteers |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026